Navigation Links
New Study Demonstrates Ramelteon Does Not Exacerbate Respiratory Depressant Effects in Patients With Moderate-to-Severe COPD
Date:12/3/2007

ORLANDO, Fla., Dec. 3 /PRNewswire/ -- A new study presented today showed that ramelteon did not exacerbate respiratory depressant effects in patients (40 years and older) with moderate to severe chronic obstructive pulmonary disease (COPD), as measured by oxygenation or abnormal breathing events relative to placebo. Results of this double-blind, placebo-controlled trial were presented at the 53rd International Respiratory Congress of the American Association for Respiratory Care.

"Getting adequate sleep is essential to maintaining health in people who live with COPD. These results suggest that ramelteon is a sleep medication that can be used safely in adults suffering from moderate to severe COPD who are concerned with breathing impairment during sleep," said Thomas Roth, PhD, director, Henry Ford Sleep Research and Disorders Center. "While traditional sleep aids can negatively affect respiration during sleep in patients with COPD, this study demonstrated that ramelteon does not produce such respiratory depressant effects."

According to the National Institutes of Health, more than 12 million Americans are currently diagnosed with COPD. It is the fourth leading cause of death in the United States and causes serious, long-term disability.

"Patients with COPD -- usually characterized by a combination of chronic bronchitis and emphysema -- must take extreme care in ensuring they receive enough oxygen at all times, particularly when sleeping. Other medications used for insomnia may reduce upper airway muscle tone, which can lead to increased hypoxemia," said Dr. Roth. "This study shows that there was no difference in blood oxygen saturation all night between placebo and ramelteon."

Study Design

A total of 25 adults age 40 or older with moderate to severe COPD were randomized to receive ramelteon 8 mg or placebo 30 minutes before overnight monitoring of oxygen saturation (SaO2) by pulse oximetry and sleep by polysomnography. After
'/>"/>

SOURCE Takeda Pharmaceuticals North America, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 2014 5i Sciences, a medical technology ... of Molly Coye, M.D., M.P.H. to a role as ... authority on the market introduction of innovative technologies that ... will advise on strategies for building a successful commercial ... Dr. Coye is currently the Chief Innovation Officer ...
(Date:7/22/2014)... 2014 The Middle East Drilling fluid and ... and completion fluid market in Middle East with analysis and ... in Middle East is estimated to grow from around $560 ... CAGR of 5.7%, for the given period. , Browse through ... fluid Market report, to get an idea of the in-depth ...
(Date:7/22/2014)... Marine threats from human or natural agents ... and international criminal and piracy threats have created ... systems. Due to this the worldwide revenue of ... 2014 and is expected to reach $20.87 billion ... expected to grow at a CAGR of 8.40%. ...
(Date:7/22/2014)... Steven Reinberg HealthDay Reporter ... tests may one day help predict survival and the course ... also called Lou Gehrig,s disease, Italian researchers report. , , ... how fast ALS is progressing are called albumin and creatinine. ... health, according to the U.S. National Library of Medicine. ...
(Date:7/22/2014)... has received a five-year, $3 million grant to ... neglect and maltreatment during childhood leave molecular marks ... life. , The Center for Biomarker Research and ... in collaboration with Duke University School of Medicine, ... by the National Institutes of Health, National Institute ...
Breaking Medicine News(10 mins):Health News:5i Sciences Announces Appointment of a Senior Healthcare Consultant and Successful Financing 2Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 5Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 6Health News:North America Maritime Security Market is Expected to Reach $4.76 billion in 2019 - New Report by MicroMarket Monitor 2Health News:North America Maritime Security Market is Expected to Reach $4.76 billion in 2019 - New Report by MicroMarket Monitor 3Health News:North America Maritime Security Market is Expected to Reach $4.76 billion in 2019 - New Report by MicroMarket Monitor 4Health News:Blood Test Might Help Predict Survival With Lou Gehrig's Disease 2Health News:Blood Test Might Help Predict Survival With Lou Gehrig's Disease 3Health News:VCU receives grant to study molecular marks left by childhood adverse experiences 2
... ... Programs Aimed at Helping College Students Stay Fit , ... Los Angeles, CA (PRWEB) July 1, 2010 -- O2 MAX Fitness , a ... the use of social media and dynamic programs, will unveil a whole new line of initiatives ...
... , THURSDAY, July 1 (HealthDay News) -- ... uterine fibroids and helps women with the non-cancerous tumors ... pain and heavy menstrual bleeding, are a leading cause ... "Both the fibroids and the surgical interventions commonly used ...
... The Good Nite ... (Parent Tested, Parent Approved) awards their industry-renowned seal of approval to products that its parent ... , ... -- The Good Nite Lite has been awarded the Parent Tested Parent Approved ...
... Health cardiologists shows that while short-term worsening kidney function ... also have better outcomes than those who have persistent ... 2010 edition of the Journal of Cardiac Failure ... for patients with heart failure that develop kidney problems ...
... ... today that it has expanded the implementation of its state-of-the-art Electronic Medical Records (EMR) system ... Westchester, Rockland, Putnam and Orange Counties and northern New Jersey. All of our Westchester, Putnam, ... ...
... , ... Purity Products®, a leading direct-to-consumer provider of premium dietary supplements, announces the release ... relaxation. , ... (PRWEB) July 1, 2010 -- Purity Products®, a leading direct-to-consumer provider of ...
Cached Medicine News:Health News:Fighting Off the Freshman Fifteen 2Health News:Fighting Off the Freshman Fifteen 3Health News:Drug May Shrink Fibroids, Preserve Fertility 2Health News:The Good Nite Lite Awarded the Parent Tested Parent Approved Seal 2Health News:Study shows short-term kidney failure in heart patients may not be as detrimental 2Health News:ENT and Allergy Associates, LLP Expands its New Electronic Practice Management System (EMR) 2Health News:ENT and Allergy Associates, LLP Expands its New Electronic Practice Management System (EMR) 3Health News:Purity Products Releases Alpha 3C 2
(Date:7/22/2014)... , July 22, 2014 The number of ... 45 people each day. Twenty-three percent of the workforce ... on Drug Use and Health, making opioid use a ... taking opioid painkillers at the correct dosage with a ... Today, the National Safety Council released ...
(Date:7/22/2014)... July 22, 2014 BiologicTx ® today ... first 3-way Kidney Paired Donation transplant exchange utilizing BiologicTx,s ... on July 9 at the Miami Transplant Institute, located ... Kidney Paired Donation (KPD) ... compatible for kidney transplant with one another due to ...
(Date:7/22/2014)... , July 22, 2014 Elekta (NSE:EKTAb) and ... that The Christie NHS Foundation Trust ( Manchester, ... a consortium whose mission is to develop the clinical ... radiation therapy system. Such a system would, in principle, ... cancer targets. "The Christie was an ...
Breaking Medicine Technology:5 things employers should know about prescription painkiller use 25 things employers should know about prescription painkiller use 3BiologicTx Paired Donation Aids In Successful Kidney Transplants 2BiologicTx Paired Donation Aids In Successful Kidney Transplants 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 2The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 4
... 1 Neurobiological Technologies, Inc. (NTI(R)) (Nasdaq: ... a quarterly royalty payment of approximately $1.5 million ... Memantine for the treatment of Alzheimer,s disease. Under ... royalty payments on certain sales of Memantine by ...
... Inc. (OTC Bulletin Board: SCIE) , a San Diego based ... an article reporting that its LUMA cervical imaging system is enhancing ... . Since Last July, researchers at the University ... LUMA Cervical Imaging System in more than 80 women - in ...
Cached Medicine Technology:Des Moines Register Reports SpectraScience LUMA Enhances Cervical Cancer Exams 2Des Moines Register Reports SpectraScience LUMA Enhances Cervical Cancer Exams 3
UST-675-P is our end-fire prostate transducer. Multiple frequencies provide extraordinary imaging capabilities for your diverse patient population, and the biopsy guide enables accurate and fast pros...
Super High Density 360 degree radial rectal transducer. High resolution in the near field and lower frequencies for deeper penetration make this transducer the optimal choice when scanning the anal c...
Our most versatile transducer for superficial imaging. Wide Band, Super High Density, multi-frequency transducer with superb Doppler and color flow sensitivity make this an excellent choice for breas...
... 5545 linear transducer is our high ... superficial and vascular imaging. Multiple frequencies ... sensitivity combined with our exclusive transducer ... PixelFocus to provide excellent resolution and ...
Medicine Products: